Ciencias de la Salud

URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/813

Examinar

Resultados de la búsqueda

Mostrando 1 - 4 de 4
  • Item type:Ítem,
    Evaluación de la “lipocalina asociada a la gеlatinasa de nеutrófilos” como biomarcador temprano de daño renal en pacientes diabéticos
    (2025-07-01)
    Ricachi Guevara, Andrea Michelle
    ;
    De la Torre Fiallos, Ana Verónica,Lcda. Mg
    ;
    Universidad Técnica de Ambato / Facultad de Ciencias de la Salud / Carrera de Laboratorio Clínico
    NGAL is an early biomarker for the detection of tubular renal injury and early-stage renal failure in patients with type 2 diabetes mellitus, as its serum concentration increases within two hours of injury and precedes the rise in serum creatinine levels by approximately 24 hours. It demonstrates superior diagnostic performance compared to traditional biomarkers such as creatinine, microalbuminuria, albuminuria, cystatin C, and KIM-1, with sensitivity and specificityranging from 90 to 95%. Elevated levels of NGAL in urine or serum indicate both proximal and distal tubular damage. In the proximal tubule, injury leads to impaired reabsorption of NGAL, whereas in the distal tubule, cellular stress induces active overproduction and secretion of the protein. This phenomenon is associated with oxidative stress and inflammation, which in turn activate signaling pathways such as JAK-STAT. Upon activation, JAK (a tyrosine kinase) phosphorylates STAT proteins, promoting their translocation into the nucleus where they regulate the transcription of genes involved in pro-inflammatory cytokine production, growth factor expression, and other mediators that contribute to fibrosis and the progression of diabetic nephropathy. Rapid immunoassays, including immunochromatography, ELISA, and quantitative PCR, are essential methodologies for NGAL quantification. When combined with complementary biomarkers such as KIM-1 or cystatin C, diagnostic accuracy in glomerular disease is significantly enhanced. Although pharmacological inhibition of NGAL could potentially delay the onset of renal fibrosis, its protective role suggests that modulating rather than suppressing its expression may be a more appropriate therapeutic strategy
  • Item type:Ítem,
    Metagenómica en el diagnóstico y seguimiento de enfermedades inflamatorias intestinales
    (2025-07-01)
    Chisaguano Masaquiza Miguel Angel
    ;
    Ramos Ramírez Martha Cecilia, Bqf. Mg.
    ;
    Universidad Técnica de Ambato / Facultad de Ciencias de la Salud / Carrera de Laboratorio Clínico
    Introduction: Inflammatory bowel disease (IBD) is a chronic disorder characterized by inflammation in structures of the digestive system. In this context, metagenomics has become established as a useful tool in the diagnosis and monitoring of IBD, since it is responsible for studying the sequencing of microbial DNA in a community, determining its microbial lineages and genes, as well as protein components in both the community of microorganisms and their metabolic network. Objective: To evaluate the best available scientific evidence on the role of metagenomics in inflammatory bowel diseases. Method: A bibliographic review was conducted during the period 2012-2025 using the PRISMA method. Results: Most studies show frequent modifications in the intestinal microbiota of patients with IBD. In bacterial communities, there was a reduction in Faecalibacterium prausnitzii and an increase in adherent-invasive Escherichia coli, while other investigations indicated a close relationship between metagenomic profiles and their usefulness in the prognosis and clinical monitoring of the disease. Conclusion: Metagenomics has allowed a significant understanding of IBD, which has identified specific traits such as: dysbiosis, modification of metabolic pathways and diagnostic biomarkers of IBD
  • Item type:Ítem,
    AVANCES EN LOS MÉTODOS SEROLÓGICOS Y MOLECULARES PARA EL DIAGNÓSTICO DE TUBERCULOSIS LATENTE
    (2025-02-25)
    Albán Balseca, Jessy Marianela
    ;
    Galárraga, Pérez Edison Arturo
    ;
    Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Laboratorio Clínico
    Introduction: tuberculosis (TB) is an infectious pathology of bacterial origin that is transmitted mainly by air. This disease is caused by Mycobacterium tuberculosis (MTB) and its main area of involvement is the lungs. Clinically, tuberculosis can manifest itself from a non-communicable and asymptomatic latent infection (LTBI) to a highly transmissible active disease. An essential aspect to obtain adequate control of the disease is the detection and diagnosis of both infectious and active cases, in order to interrupt the chain of TB transmission. Objectives: to evaluate the usefulness, efficacy and clinical accuracy of the serological and molecular methods currently used to detect latent tuberculosis. Methods: a bibliographic review was carried out using the PRISMA method. Clinical studies and systematic reviews were included, highlighting those with relevant information on the diagnostic advances used in laboratories for the detection of TB. Results: currently, the interferon gamma release assay (IGRA) and the tuberculin skin test (TST) are used to establish the diagnosis of TB. However, molecular tests such as GeneXpert MTB/RIF, LAMP, PCR have revolutionized the diagnosis of active tuberculosis by offering significant advances in terms of speed, accuracy and accessibility. Conclusions: tests for the diagnosis of tuberculosis include different traditional techniques such as microscopy and culture, as well as innovative molecular and immunodiagnostic tests. However, each of these strategies has its strengths and limitations, so this topic remains a necessary area of research to achieve the eradication of the disease.
  • Item type:Ítem,
    CARGA EXOSOMAL: BIOMARCADORES EN EL DIAGNÓSTICO DEL CÁNCER
    (2025-02-25)
    Campoverde Ortega, Gabriela Noemi
    ;
    Proaño Pérez, María Elizabeth
    ;
    Universidad Técnica de Ambato/ Facultad de Ciencias de Salud /Carrera de Laboratorio Clínico
    Cancer is a global health problem, and one of its main challenges is timely detection. Therefore, the determination of exosomal biomarkers has been proposed as a possible tool when diagnosing this pathology. In addition to being important elements in intracellular communication by transporting cellular biomolecules such as lipids, nucleic acids, proteins, and metabolites associated with their producer cell, they act as main regulators of the tumor microenvironment, responsible for angiogenesis, progression, and development of metastasis. For their isolation, there are various techniques related to ultracentrifugation, ultrafiltration, and immunoaffinity that allow their separation from different sources, whether biological fluids or culture media, facilitating their study in the context of cancer.